Evidence map›Paper›PMID 35878309›Full record

ArticleToxics2022

Development and Applications of a Zebrafish (

Amy L Anderson, Benjamin D Dubanksy, Lindsay B Wilson, Robyn L Tanguay, Charles D Rice

Open access · goldAbstract read
In one paragraph

Article in Toxics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Aryl hydrocarbon receptor-dependent toxicity by retene requires metabolic competence.Toxicological sciences : an official journal of the Society of Toxicology · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Amy L AndersonGraduate Program in Environmental Toxicology, Department of Biological Sciences, Clemson University, Clemson, SC 29634, USA.
Benjamin D DubanksyDepartment of Comparative Biomedical Sciences, Louisiana State University, Baton Rouge, LA 70803, USA.
Lindsay B WilsonDepartment of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97333, USA.
Robyn L TanguayDepartment of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97333, USA.ORCID 0000-0001-6190-3682
Charles D RiceGraduate Program in Environmental Toxicology, Department of Biological Sciences, Clemson University, Clemson, SC 29634, USA.ORCID 0000-0002-5352-9165
Clemson University · USOregon State University · USLouisiana State University · US

Funding

Research Experience and Training Coordination CoreP42ES016465 · NIEHS · OREGON STATE UNIVERSITY · PI Robyn L Tanguay · 2009 to 2026
$52.5M
Zebrafish Biomedical Research Facility CoreP30ES030287 · NIEHS · OREGON STATE UNIVERSITY · PI Molly L Kile · 2020 to 2026
$9.8M
Mechanisms of Immunological Adaptation to a Harsh Chemical EnvironmentR15ES016905 · NIEHS · CLEMSON UNIVERSITY · PI RICE, CHARLES D · 2009 to 2009
$223k
PCBS &ESTROGENS ON PROINFLAMMATORY PHAGOCYTE FUNCTIONSR15ES010556 · NIEHS · CLEMSON UNIVERSITY · PI RICE, CHARLES D · 2000 to 2000
$140k
NIEHS NIH HHS P30 ES030287NIEHS NIH HHS P42 ES016465NIEHS NIH HHS R15 ES016905NIH HHS P30 ES030287NIH HHS P42 ES016465NIH HHS R15ES010556NIH HHS R15ES016905
6 · The paper itself

Abstract

CYP1A is a heme-thiolate enzyme associated with the cytochrome P4501A1 monooxygenase system and is inducible by a wide variety of xenobiotics and endogenous ligands that bind and activate the aryl hydrocarbon receptor (AHR). The AHR-CYP1A axis is important for detoxification of certain xenobiotics and for homeostatic balance of endogenous sex hormones, amine hormones, vitamins, fatty acids, and phospholipids. Herein, we generated and described applications of a zebrafish CYP1A-targeted monoclonal antibody (mAb CRC4) that fortuitously recognizes induced CYP1A across vertebrate taxa, including fish, chicken, mouse, rat, and human. We then demonstrated that mAb CRC4 targets a highly conserved epitope signature of vertebrate CYP1A. The unique complimentary determining region (CDR) sequences of heavy and light chains were determined, and these Ig sequences will allow for the expression of recombinant mAb CRC4, thus superseding the need for long-term hybridoma maintenance. This antibody works well for immunohistochemistry (IHC), as well as whole-mounted IHC in zebrafish embryos. Monoclonal antibody CRC4 may be particularly useful for studying the AHR-CYP1A axis in multiple vertebrate species and within the context of Oceans and Human Health research. By using archived samples, when possible, we actively promoted efforts to reduce, replace, and refine studies involving live animals.

Indexed as

conserved CYP1A epitopemonoclonal antibody (mAb) CRC4vertebrate CYP1Awhole mount IHCzebrafish CYP1A

Identifiers

PMID35878309
PMCPMC9320060
OpenAlexW4286502910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.